Studies how stress signaling influences amyloid deposition, tau phosphorylation, and cognitive decline in Alzheimer's disease. Uses transgenic models, in vivo pharmacology, and multiplex bioassays to investigate corticotropin-releasing-factor pathways and develop biomarkers for preclinical disease and treatment response.